Point72 Asset Management
HALO icon

Point72 Asset Management’s Halozyme HALO Stock Holding History

Point72 Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-582,400
Closed -$5.75M – 862
2016
Q4 		$5.75M Buy
+582,400
New +$6.38M 0.04% 425

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asset Management's HALO Position: Q1 2025 in Review

Point72 Asset Management sold out of Halozyme (HALO) in Q1 2025, closing a stake of 84,832 shares — an estimated $4.06M sold.

Point72 Asset Management first reported a position in HALO in Q2 2019 and held it in 13 quarters. The position peaked at $20.4M in Q2 2019. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Point72 Asset Management reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 84,832 Halozyme shares in Q1 2025, an estimated $4.06M.
  • Point72 Asset Management first reported a position in Halozyme in Q2 2019 and held it in 13 quarters.
  • Point72 Asset Management's Halozyme position peaked at $20.4M in Q2 2019.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.